Clinical Trials Directory

Trials / Completed

CompletedNCT00610597

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (CD4+ T cell secreting Interleukin-17) Th17 pathway is involved in alcoholic liver disease.

Detailed description

Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels, peripheral blood mononuclear cells cytokine release and liver T cell infiltrates.

Conditions

Timeline

Start date
2005-01-01
Primary completion
2007-01-01
Completion
2008-01-01
First posted
2008-02-08
Last updated
2008-02-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00610597. Inclusion in this directory is not an endorsement.

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease (NCT00610597) · Clinical Trials Directory